- Home
- DYN vs CENT Comparison
DYN vs CENT Comparison
Compare DYN & CENT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DYN
- CENT
- Stock Information
- Founded
- DYN 1984
- CENT 1955
- Country
- DYN United States
- CENT United States
- Employees
- DYN N/A
- CENT N/A
- Industry
- DYN Medicinal Chemicals and Botanical Products
- CENT Consumer Specialties
- Sector
- DYN Health Care
- CENT Consumer Discretionary
- Exchange
- DYN Nasdaq
- CENT Nasdaq
- Market Cap
- DYN 1.9B
- CENT 2.2B
- IPO Year
- DYN 2020
- CENT N/A
- Fundamental
- Price
- DYN $22.76
- CENT $30.95
- Analyst Decision
- DYN Strong Buy
- CENT Strong Buy
- Analyst Count
- DYN 14
- CENT 1
- Target Price
- DYN $34.93
- CENT $45.00
- AVG Volume (30 Days)
- DYN 2.9M
- CENT 67.1K
- Earning Date
- DYN 10-28-2025
- CENT 11-24-2025
- Dividend Yield
- DYN N/A
- CENT N/A
- EPS Growth
- DYN N/A
- CENT N/A
- EPS
- DYN N/A
- CENT 2.14
- Revenue
- DYN N/A
- CENT $3,120,375,000.00
- Revenue This Year
- DYN N/A
- CENT N/A
- Revenue Next Year
- DYN N/A
- CENT $0.16
- P/E Ratio
- DYN N/A
- CENT $14.60
- Revenue Growth
- DYN N/A
- CENT N/A
- 52 Week Low
- DYN $6.36
- CENT $28.77
- 52 Week High
- DYN $35.68
- CENT $43.88
- Technical
- Relative Strength Index (RSI)
- DYN 74.02
- CENT 41.30
- Support Level
- DYN $23.05
- CENT $30.86
- Resistance Level
- DYN $25.00
- CENT $32.60
- Average True Range (ATR)
- DYN 1.00
- CENT 0.66
- MACD
- DYN 0.72
- CENT 0.25
- Stochastic Oscillator
- DYN 78.19
- CENT 56.99
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.
About CENT Central Garden & Pet Company
Central Garden & Pet Co understands that home is central to life and has nurtured happy and healthy homes for over forty years. The segments of the company are the pet segment and garden segment. The company's trusted products are dedicated to helping lawns grow greener, gardens bloom bigger, pets live healthier and communities grow stronger. Central is home to a portfolio of more than sixty-five brands including Pennington, Nylabone, Kaytee, Amdro, and Aqueon, manufacturing and distribution capabilities, and a passionate, entrepreneurial growth culture. Central Garden and Pet is based in Walnut Creek, California, and has offices across North America and Europe.